Cargando…

Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population

Background: Screening colonoscopy aims to interrupt the adenoma-carcinoma sequence by removing all precancerous adenomatous polyps. Adenomatous polyp detection rate (ADR) can vary between endoscopists as well as between race, age, and risk of colorectal cancer (CRC). The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundumadam, Shanker, Naseer, Maliha, Kaloti, Zaid, Kiwan, Wissam, Kathi, Pradeep R, Nas, Hala, Naylor, Paul H, Al-Subee, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876912/
https://www.ncbi.nlm.nih.gov/pubmed/31807390
http://dx.doi.org/10.7759/cureus.6003
_version_ 1783473287059210240
author Kundumadam, Shanker
Naseer, Maliha
Kaloti, Zaid
Kiwan, Wissam
Kathi, Pradeep R
Nas, Hala
Naylor, Paul H
Al-Subee, Omar
author_facet Kundumadam, Shanker
Naseer, Maliha
Kaloti, Zaid
Kiwan, Wissam
Kathi, Pradeep R
Nas, Hala
Naylor, Paul H
Al-Subee, Omar
author_sort Kundumadam, Shanker
collection PubMed
description Background: Screening colonoscopy aims to interrupt the adenoma-carcinoma sequence by removing all precancerous adenomatous polyps. Adenomatous polyp detection rate (ADR) can vary between endoscopists as well as between race, age, and risk of colorectal cancer (CRC). The purpose of this study was to compare ADR among academic gastroenterologists (A-GI), non-A-GI, and surgeons for endoscopies performed in the same endoscopic suite of a large medical center with a predominately African American (AA) population. Methods: All screening colonoscopies performed in 2014 for patients aged 62-76 years were identified using the electronic medical records data. Patients with average risk and high risk of CRC defined as having a 'personal history of polyps' or 'family history of CRC', and history of ulcerative colitis and Fecal Occult Blood Test/Fecal Immunochemical Test (FOBT/FIT) positivity were included. Patients with incomplete colonoscopy (defined as failing to achieve cecal intubation or poor preparation) and unrecovered tissue biopsy were excluded. ADR was calculated for three groups of endoscopists: A-GIs, non-A-GIs, and surgeons. Results: A total of 573 screening colonoscopies was analyzed. The endoscopists comprised five A-GIs, eight non-A-GIs, and six surgeons. The majority of patients were of AA decent (71%), female (54%) with an average age of 66 years. Patients classified as average risk comprised 79% of the population. Most of the colonoscopies were performed by A-GI (n=339), followed by non-A-GI (n=144), and surgeons (n=90). The ADR for A-GI was 50% as compared to 32% for non-A-GI (p<0.001) and 25% for surgeons (p<0.001). Also, A-GI were more likely to identify ≥3 adenomas during screening colonoscopies. Significant differences were observed (p<0.001) in the mean time of colonoscopy for A-GI (30 mins) non-A-G (14 mins), and surgeons (18 mins). Conclusion: Significant variation in the ADR between endoscopists belonging to different specialties were observed. Although all appear to achieve acceptable ADR (ie at least 25 for men and 15 for women), academic gastroenterologists had better performance than non-academic GI and surgeons. This may be explained by a significantly longer average duration of procedures for the highest ADR group.
format Online
Article
Text
id pubmed-6876912
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68769122019-12-05 Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population Kundumadam, Shanker Naseer, Maliha Kaloti, Zaid Kiwan, Wissam Kathi, Pradeep R Nas, Hala Naylor, Paul H Al-Subee, Omar Cureus Gastroenterology Background: Screening colonoscopy aims to interrupt the adenoma-carcinoma sequence by removing all precancerous adenomatous polyps. Adenomatous polyp detection rate (ADR) can vary between endoscopists as well as between race, age, and risk of colorectal cancer (CRC). The purpose of this study was to compare ADR among academic gastroenterologists (A-GI), non-A-GI, and surgeons for endoscopies performed in the same endoscopic suite of a large medical center with a predominately African American (AA) population. Methods: All screening colonoscopies performed in 2014 for patients aged 62-76 years were identified using the electronic medical records data. Patients with average risk and high risk of CRC defined as having a 'personal history of polyps' or 'family history of CRC', and history of ulcerative colitis and Fecal Occult Blood Test/Fecal Immunochemical Test (FOBT/FIT) positivity were included. Patients with incomplete colonoscopy (defined as failing to achieve cecal intubation or poor preparation) and unrecovered tissue biopsy were excluded. ADR was calculated for three groups of endoscopists: A-GIs, non-A-GIs, and surgeons. Results: A total of 573 screening colonoscopies was analyzed. The endoscopists comprised five A-GIs, eight non-A-GIs, and six surgeons. The majority of patients were of AA decent (71%), female (54%) with an average age of 66 years. Patients classified as average risk comprised 79% of the population. Most of the colonoscopies were performed by A-GI (n=339), followed by non-A-GI (n=144), and surgeons (n=90). The ADR for A-GI was 50% as compared to 32% for non-A-GI (p<0.001) and 25% for surgeons (p<0.001). Also, A-GI were more likely to identify ≥3 adenomas during screening colonoscopies. Significant differences were observed (p<0.001) in the mean time of colonoscopy for A-GI (30 mins) non-A-G (14 mins), and surgeons (18 mins). Conclusion: Significant variation in the ADR between endoscopists belonging to different specialties were observed. Although all appear to achieve acceptable ADR (ie at least 25 for men and 15 for women), academic gastroenterologists had better performance than non-academic GI and surgeons. This may be explained by a significantly longer average duration of procedures for the highest ADR group. Cureus 2019-10-26 /pmc/articles/PMC6876912/ /pubmed/31807390 http://dx.doi.org/10.7759/cureus.6003 Text en Copyright © 2019, Kundumadam et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Kundumadam, Shanker
Naseer, Maliha
Kaloti, Zaid
Kiwan, Wissam
Kathi, Pradeep R
Nas, Hala
Naylor, Paul H
Al-Subee, Omar
Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title_full Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title_fullStr Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title_full_unstemmed Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title_short Variations in Screening Adenoma Detection Rate by Specialty of Physicians in a Predominately African American Population
title_sort variations in screening adenoma detection rate by specialty of physicians in a predominately african american population
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876912/
https://www.ncbi.nlm.nih.gov/pubmed/31807390
http://dx.doi.org/10.7759/cureus.6003
work_keys_str_mv AT kundumadamshanker variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT naseermaliha variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT kalotizaid variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT kiwanwissam variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT kathipradeepr variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT nashala variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT naylorpaulh variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation
AT alsubeeomar variationsinscreeningadenomadetectionratebyspecialtyofphysiciansinapredominatelyafricanamericanpopulation